Valuation: Orchid Pharma Limited

Capitalization 3.72TCr 43Cr 37Cr 34Cr 32Cr 59Cr 66Cr 416.64Cr 157.28Cr 1.74TCr 161.82Cr 158.47Cr 6.4TCr P/E ratio 2025
39.5x
P/E ratio 2026 * 33.8x
Enterprise value 3.53TCr 41Cr 35Cr 33Cr 30Cr 56Cr 63Cr 395.65Cr 149.35Cr 1.65TCr 153.67Cr 150.48Cr 6.08TCr EV / Sales 2025
4.26x
EV / Sales 2026 * 2.43x
Free-Float
30.16%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.19%
1 week+1.98%
Current month+2.55%
1 month+5.96%
3 months-5.59%
6 months-55.00%
Current year-59.46%
More quotes
1 week 715
Extreme 715
758.8
1 month 678
Extreme 678
768.75
Current year 603.8
Extreme 603.8
1,997.4
1 year 603.8
Extreme 603.8
1,997.4
3 years 296.1
Extreme 296.1
1,997.4
5 years 17.5
Extreme 17.5
2,654.25
10 years 17.5
Extreme 17.5
2,654.25
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 31/03/2020
Director of Finance/CFO - 29/06/2020
Compliance Officer - 16/12/2023
Director TitleAgeSince
Chairman 76 31/03/2020
Director/Board Member 57 31/03/2020
Director/Board Member 43 31/03/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.19%+1.98%-37.05%+143.29% 43Cr
+1.34%-2.69%-9.09%+139.83% 69TCr
+0.44%+4.33%+5.33%-6.04% 39TCr
-1.12%-1.66%+10.59%+26.54% 33TCr
-2.22%-5.55%-53.26%-1.90% 29TCr
+0.58%+0.66%-7.15%-21.43% 26TCr
-1.12%-4.09%-2.94%+12.40% 22TCr
-0.17%-1.49%-15.11%-7.23% 21TCr
-1.91%-4.08%-35.65%-13.41% 20TCr
-1.17%-0.17%-10.94%+20.88% 16TCr
Average -0.58%-1.37%-15.53%+29.29% 27.65TCr
Weighted average by Cap. -0.41%-1.66%-11.08%+35.86%
See all sector performances

Financials

2025 2026 *
Net sales 928.8Cr 11Cr 9.25Cr 8.62Cr 8.02Cr 15Cr 17Cr 104.15Cr 39Cr 435.47Cr 40Cr 40Cr 1.6TCr 1.45TCr 17Cr 14Cr 13Cr 13Cr 23Cr 26Cr 162.39Cr 61Cr 678.97Cr 63Cr 62Cr 2.5TCr
Net income 96Cr 1.12Cr 95.84L 89.3L 83.08L 1.53Cr 1.71Cr 11Cr 4.07Cr 45Cr 4.19Cr 4.1Cr 165.79Cr 131.8Cr 1.53Cr 1.31Cr 1.22Cr 1.14Cr 2.1Cr 2.34Cr 15Cr 5.58Cr 62Cr 5.74Cr 5.62Cr 227.15Cr
Net Debt -187.2Cr -2.17Cr -1.86Cr -1.74Cr -1.62Cr -2.98Cr -3.33Cr -21Cr -7.92Cr -88Cr -8.15Cr -7.98Cr -322.62Cr -190.4Cr -2.21Cr -1.9Cr -1.77Cr -1.64Cr -3.03Cr -3.39Cr -21Cr -8.06Cr -89Cr -8.29Cr -8.12Cr -328.14Cr
More financial data * Estimated data
Logo Orchid Pharma Limited
Orchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of formulations and active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, and Veterinary Products. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Bio-Pharma Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc. and Diakron Pharmaceuticals, Inc.
Employees
871
More about the company
Date Price Change Volume
18/25/18 732.55 -1.19% 70,500
17/25/17 741.35 -1.00% 75,632
16/25/16 748.85 +1.20% 69,603
15/25/15 739.95 +2.76% 1,94,628
14/25/14 720.05 +0.24% 1,02,016

Delayed Quote NSE India S.E., July 18, 2025 at 05:19 pm IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
732.55INR
Average target price
1,000.67INR
Spread / Average Target
+36.60%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ORCHPHARMA Stock